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Acute transfusion reactions encountered in patients at a tertiary care center
Safoorah Khalid, Mohammad Usman, Mohammad Khurshid
Laboratory Department, Dr. Sulaiman Al Habib Medical Group, King Fahad Road, Olaya Riyadh, Kingdom of Saudi Arabia.
Abstract
Objective: To determine the frequency and type of Acute Transfusion Reactions (ATRs) occurring in inpatients,
reported to the transfusion service at Aga Khan University Hospital, Karachi, Pakistan.
Methods: This was a three years and seven months (from January 2005 till July 2008) retrospective review of
all the transfusion reactions that were reported to the transfusion service at Aga Khan University Hospital,
Karachi, Pakistan. All the reactions were clinically evaluated by the blood bank physician. Transfusion reactions
occurring during or within four hours after transfusion were evaluated and classified by standard and recognized
definitions defined by American Association of Blood Banks.
Results: The acute transfusion reactions (ATRs) reported during the study period were 212. However, out of
these 212 ATRs, 182 ATRs were confirmed by blood bank physician, and included febrile non haemolytic
reactions [89 (41.9%)], allergic reaction [73 (34.4%)], isolated hypotension [3 (1.4%)], haemolytic reaction [4
(1.8%)] and bacterial contamination [2 (0.9%)]. Eleven (5.1%) ATRs were unclassifiable and were thus labeled
as non specific reaction. 
Conclusion: The frequency of transfusion reactions in our patients was found to be 0.082%. Febrile non
haemolytic reaction was the most frequent transfusion reaction followed by allergic reaction. This may be an
under reported figure. There is a need for establishing a haemovigilance system for critical analysis of blood
transfusion events (JPMA 60:832; 2010).
Introduction
Transfusion of blood products is often required
with the aim of improving the blood counts and clinical
condition of the patients. However, transfusion can lead to
serious adverse effects including infectious and non-
infectious complications. With the improvements in donor
screening and infectious diseases testing, the risk of
infectious complications has declined in the past few
decades. But the risks of non- infectious complications
have become more apparent. These non- infectious
complications can occur rapidly after transfusion (acute)
or many days and/ or weeks after transfusion (delayed).1
Acute transfusion reactions (ATRs) occur within 24 hours
of administration of transfusion and most of them occurs
within the first four hours. Commonly encountered ATRs
include acute haemolytic reaction, febrile non-haemolytic
reaction, allergic reaction, volume overload, bacterial
contamination and isolated hypotension.2 These ATRs
have different etiology, clinical presentation and severity.
However, most of these reactions are usually mild and
transient.
The frequency of ATRs is estimated to be 0.2% to
10%2-4 and are responsible for death in approximately 1 per
250,000.3
Haemovigilance consists of reporting of all the
complications related to transfusion so that these can be
avoided in the future. Various haemovigilance
programmmes have been developed and implemented in
several countries including Canada, United Kingdom and
France; and they publish their annual reports of adverse
events associated with blood transfusion.4-6 The aim of
these programmmes is to have a system of surveillance and
thus lower the risks associated with transfusion.
Unfortunately, there is no such programmme in Pakistan
and the reporting of transfusion hazards is not mandatory.
Also there is under reporting by the medical staff and thus
most of the minor adverse events do not come to attention
and therefore the exact incidence of various types of
transfusion reactions is not known.
Keeping this in mind, the primary objective of the
study was to determine the frequency and type of ATRs
occurring in hospitalized patients who required transfusion at
a tertiary care center in Pakistan.
Patients and Methods
This was a three years and seven months (from
January 2005 till July 2008) retrospective review of all the
transfusion reactions that were reported to the transfusion
service at Aga Khan University Hospital, Karachi, Pakistan.
All the reactions were clinically evaluated by the blood bank
physician. 
An algorithm was already provided to the medical
staff in the ward on how to proceed with clinical and
laboratory investigations whenever any transfusion reaction
occurred. All the details were noted on a transfusion reaction
form. In case of any transfusion reaction, pre-transfusion data
that was collected included patient's identification number,
ABO and Rh group of the patient, type of blood product
transfused, donor number and blood group, date and time of
starting transfusion and patient's vital signs. Post-transfusion
data included date and time of stopping transfusion,
approximate volume transfused, type of reaction noted and
patient's vital signs.
As part of the routine transfusion reaction evaluation,
the patient's blood sample and blood component(s) were
checked for clerical errors; the serum or plasma in a post
reaction blood sample was inspected for any evidence of
haemolysis and compared with a pre reaction sample, if
available. The tests performed after the occurrence of
transfusion reaction were patient's ABO and Rh group on pre
and post reaction samples, donor's ABO and Rh group,
patient and donor re-cross matching on pre and post reaction
samples, direct antiglobulin test (DAT) on patient's pre and
post reaction samples, complete blood picture and peripheral
blood film on post reaction sample, patient's urine detailed
report and blood bag culture. 
Transfusion reactions occurring during or within
four hours after transfusion were evaluated. Based on the
clinical features experienced by the recipient and
laboratory parameters, these reactions were classified by
standards and recognized definitions defined by American
Association of Blood Banks.7 Febrile non haemolytic
reaction was defined as a temperature increase of more
than 1°C and/or chills associated with transfusion without
any other explanation. Allergic reactions were associated
with cutaneous or systemic manifestations that responded
to antihistamine therapy. Immune haemolytic reactions
were diagnosed based on the clinical and/or laboratory
evidence of haemolysis and positive DAT. Non immune
hemolysis due to mechanical destruction of red cells was
suspected when the patient had hemolysis and negative
DAT. Bacterial contamination was defined as the
contamination of the blood product detected by a positive
culture of the blood product resulting in infection of the
recipient. Volume overload was manifested by respiratory
distress leading to pulmonary oedema on chest X-ray.
Isolated hypotension was marked by sudden hypotension
after starting transfusion. Transfusion related acute lung
injury (TRALI) was characterized by hypoxaemia,
respiratory failure, hypotension and fever in the absence
of cardiac failure, angioedema or bronchospasm. The
signs and symptoms, for which no direct relationship to
the transfusion could be demonstrated, were classified as
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non specific reactions.
All statistical analyses were performed using SPSS
Version 16.0 (SPSS Inc. Chicago, IL, USA). Descriptive
statistics were calculated for each of the variables. The
incidence rate of ATRs was calculated as total number of a
particular ATR (numerator) per total number of transfusions
(denominator).
Results
The total number of transfusion reactions reported
to our transfusion service during the study period was 212.
There were 115 (54.3%) females and 97 (45.7%) males
who had experienced a transfusion reaction. Mean age was
45 ± 20 years (range 0.2-88 years). The signs and
symptoms encountered included fever [n= 90 (42.4%)],
chills [n= 89 (41.9%)], urticaria [n= 76 (35.8%)],
dyspnoea/ tachypnoea [n= 27 (12.7%)], hypotension [n= 4
(1.8%)], headache/ body aches [n= 3 (1.4%)], anxiety and/
or agitation [n= 2 (0.94%)], sweating [n= 2 (0.94%)],
numbness of the extremities [n= 1 (0.47%)] and redness
around the injection site [n= 1 (0.47%)]. All the signs and
symptoms were reported within four hours of starting the
transfusion. 
All ATRs occurred with packed cells (87.7%),
platelets (7.0%) and FFP (5.1 %); none of the transfusion
reactions were observed with cryoprecipitate or granulocyte
concentrates. Overall 0.18% of packed cells, 0.02% of
platelets and 0.02% of FFP were involved in causing ATRs. 
Of the 212 transfusion reactions reported, 30
(14.1%) were not concluded because of either missing data
or failure to obtain the blood and urine samples for further
investigation. Among the 182 ATRs that were confirmed by
blood bank physician, there were febrile non haemolytic
reactions [89 (41.9%)], allergic reaction [73 (34.4%)],
isolated hypotension [3 (1.4%)], haemolytic reaction [4
(1.8%)] and bacterial contamination [2 (0.9%)]. Eleven
ATRs (5.1%) were unclassifiable and were thus labeled as
non specific reaction. Not a single case of TRALI was
observed in our study.
In case of febrile non haemolytic reactions, cultures
were performed on all the units and were found to be
negative. 
Anaphylactic shock manifested by systemic
symptoms was observed in only one patient; who responded
to symptomatic therapy. 
The two reactions that were reported as bacterial
contamination were due to gram negative rods which
were identified in patient's blood culture as well as blood
bag culture. 
Haemolytic reaction was observed in four patients.
Two of which were due to ABO incompatibility which was
a result of errors at all stages in the transfusion chain. Two
other haemolytic reactions occurred in patients who were
transfused least incompatible blood due to a history of
immune mediated haemolysis. In one of them,
alloantibodies as anti C and anti K were detected after
transfusion. However, no mortality or morbidity was
encountered in all four patients.
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Table-1: Characteristics of transfusions.
Data All transfusions Transfusions with reaction
(n= 225662) (n= 212)
Type of blood product
 Red cells 100520 (44.6) 186 (87.7)
 Platelets 67256 (29.8) 15 (7.0)
 FFP 51178 (22.7) 11 (5.1)
 Cryoprecipitate 6377 (2.9) Nil
 Granulocytes 2 (0.001) Nil
 Whole blood 329 (0.14) Nil
The percentage in parentheses represents the number of variable
per total number of transfusions.
Table-3: Number of transfusion reactions according to
the type of blood component involved.
Transfusion reactions Packed cells Platelets FFP
(n=187) (n=14) (n=11)
Febrile non haemolytic reaction 84 3 2
Allergic reaction 61 7 5
Bacterial contamination 2 Nil Nil
Isolated hypotension 3 Nil Nil
Haemolytic reaction 4 Nil Nil
Non specific reaction 11 Nil Nil
Not concluded 22 4 4
Table-2: Distribution and frequency of all transfusion reactions (Jan 2005- July 2008).
2005 2006 2007 2008 Total Frequency (%)
(n=46) (n=31) (n=69) (n=36) (n=182)
Febrile non haemolytic reaction 20 11 40 18 89 0.03
Allergic reaction 20 12 24 17 73 0.02
Bacterial contamination 1 Nil 1 Nil 2 0.0007
Isolated hypotension 1 2 Nil Nil 3 0.001
Haemolytic reaction 1 Nil 2 1 4 0.001
Non specific reaction 3 6 2 Nil 11 0.004
The total number of transfusions recorded during the
study period were 255662 and the total transfusion reactions
were 212, giving a frequency of 0.082%. The characteristics
of these transfusions are shown in Table-1. The distribution of
different types of transfusion reactions is presented in Table-
2 and the blood products that were involved in different types
of reactions are summarized in Table-3.
Discussion
To the best of our knowledge, this is the first study
that provides a detailed analysis of transfusion reactions
occurring at a single institution in Pakistan. Our results
showed that febrile non-haemolytic reaction was the most
frequent transfusion hazard followed by allergic reactions.
This is similar to other studies as well.4,8,9
Incidence rates of transfusion reactions are also
reported by various haemovigilance systems. In a report from
the transfusion service of Puerto Rico Medical services
administration,10 ATR was found to be in 0.2% of labile blood
product transfusion. The haemovigilance network in France
reported a rate of 0.25 incidents per 100 blood components
between 1994 and 1998.6 According to 2001 report of
haemovigilance system of the Canadian province of Quebec,
the incidence of ATR was 0.35% for labile blood
components.4 A university hospital in Switzerland
documented a global incidence of 4.2 incidents for 1000
blood products distributed.11
The incidence of ATRs reported in our study (0.082%)
is different from what is reported by these haemovigilance
systems. This could be due to under reporting because a
critical analysis has revealed that only the most obvious
transfusion events are reported to our transfusion service and
others are totally ignored. 
Literature search has revealed many published case
reports12-15 and haemovigilance reports16 of TRALI,
however, only a single case of TRALI has been reported so
far from Pakistan.17 We did not encounter any case of TRALI
during the study period. This could be due to the rarity of this
complication among the transfusion recipients and most
importantly this may be due to the lack of clear definition and
awareness of this potentially lethal complication among the
healthcare personnel and also due to confusion with other
conditions leading to similar clinical picture. Moreover,
specific diagnostic tests to confirm TRALI are not available
that further complicates the recognition of this reaction.
Another complication associated with transfusion i.e.
volume overload was also not encountered in our study and
this may also be due to the uncertainty about the diagnosis. 
Transfusion reaction due to ABO incompatibility was
observed in two patients. Such incidents of incorrect blood
component transfusion have also been reported in the
literature18-20 with errors occurring at all stages. 
The blood products that were involved in transfusion
reactions were packed cells, platelets and FFP with the
majority of transfusion reactions being due to packed cells.
This finding was also observed in a study conducted in a
paediatric intensive care unit;1 however they only reported
48% of transfusion reactions due to packed cells with
platelets accounting for 40% and FFP for 12%. The reason for
this difference could be because of the use of universal
leucoreduced packed cells used in this study in contrast to our
study where leucoreduction was only employed if the patient
experienced repeated febrile reactions.
The retrospective nature of our study has left many
questions unanswered. First, we did not identify the risk
factors that were present in patients who developed an ATR.
Secondly, we only reported the transfusion events that
occurred during the first four hours after transfusion since
most significant ATRs are encountered during or soon after
transfusion.1 Finally, under reporting by medical staff could
have underestimated the number of ATRs in our study. Under
reporting of minor transfusion reactions has also been
reported by Narvios AB et al.21
To avoid any of the transfusion complications, there
is a need to improve the knowledge of healthcare
professionals for prompt recognition. The medical staff
should understand the importance of reporting all major and
minor transfusion events to the transfusion service.
Improved and strict surveillance programmmes are required
to estimate the risk- benefit ratio of blood transfusion and to
identify the problems in the transfusion chain and take
measures to assure compatibility between the donor and the
recipient at all stages. Establishing a haemovigilance system
can also be a better option to gain a better understanding of
transfusion related events. The ultimate goal of all the
efforts should be to make transfusion of blood as safe as
possible for the patient. 
Conclusion
The frequency of transfusion reactions in our patients
was found to be 0.082% and there is surely an element of
under reporting in our system. We strongly feel that there is a
need for establishing a haemovigilance system in our country
that can be helpful in the detection of transfusion reactions, as
well as in the decision to take appropriate preventive
measures. 
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